These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2413430)

  • 1. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
    Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
    Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase isoenzyme (CK-BB) in combination to prostatic acid phosphatase measured by RIA in the diagnosis of prostatic cancer.
    Huber PR; Zaugg T; Linder E; Hagmaier V; Rutishauser G
    Urol Res; 1982; 10(2):75-80. PubMed ID: 6180539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia.
    Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL
    Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusually high creatine kinase BB isoenzyme and study of lactate dehydrogenase pattern in metastatic adenocarcinoma of the prostate.
    Sandhu RS; Conover RE
    Clin Biochem; 1980 Feb; 13(1):30-3. PubMed ID: 7363450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient increase in serum creatine kinase isoenzyme BB activity after prostatectomy in a patient with massive benign prostatic hyperplasia.
    Goodman ZD; Hamilton SR
    Clin Chem; 1980 Mar; 26(3):511-2. PubMed ID: 6153944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creatine kinase isoenzyme (CK-BB) by RIA as a follow-up marker in stage D cancer of the prostate: comparison with PAP RIA.
    El-Shribiny A; Bharvaga A; Fitzpatrick J; Murphy GP
    J Surg Oncol; 1985 Mar; 28(3):232-6. PubMed ID: 3974250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic significance of serum creatine kinase-BB isoenzyme in adenocarcinoma of prostate.
    Aleyassine H; MacIsaac SG
    Clin Biochem; 1980 Jun; 13(3):109-12. PubMed ID: 7418193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
    Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
    J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme immunoassay of prostatic acid phosphatase after prostatic examination. Correlation with prostate size and immunopathology.
    el-Shirbiny AM; Shridhar P; al Adnani MS; Suresh LK
    Urology; 1988 Nov; 32(5):469-73. PubMed ID: 2460989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunoassay of creatine kinase B-isoenzymes in serum of patients with azotemia, obstructive uropathy, or carcinoma of the prostate or bladder.
    Homburger HA; Miller SA; Jacob GL
    Clin Chem; 1980 Dec; 26(13):1821-4. PubMed ID: 6159995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatine kinase BB: a new tumor-associated marker.
    Silverman LM; Dermer GB; Zweig MH; Van Steirteghem AC; Tökés ZA
    Clin Chem; 1979 Aug; 25(8):1432-5. PubMed ID: 455680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate.
    Chodak GW; Kranc DM; Puy LA; Takeda H; Johnson K; Chang C
    J Urol; 1992 Mar; 147(3 Pt 2):798-803. PubMed ID: 1371552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
    Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
    Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine phosphokinase in prostatic tissue.
    Sjövall K; Rubin S; Müntzing J
    Scand J Urol Nephrol; 1975; 9(3):181-4. PubMed ID: 1209173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of prostatic acid phosphatase localization in human prostate by a monoclonal antibody with the Gleason grading system.
    Sinha AA; Gleason DF; Wilson MJ; Wick MR; Reddy PK; Blackard CE
    Prostate; 1988; 13(1):1-15. PubMed ID: 2458582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear androgen receptors of human prostatic tissue--a quantitative histological study.
    Elhilali M; Lehoux JG; Carmel M; Madarnas P; Mongeau C; Beauchesne C; Tétreault L; Bénard B
    Arch Androl; 1983 Mar; 10(1):21-7. PubMed ID: 6189463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue.
    Brolin J; Skoog L; Ekman P
    Prostate; 1992; 20(4):281-95. PubMed ID: 1376911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.